Hidradenitis Suppurativa PDA References

All decision aids are based on best available clinical evidence.

Adams, D. R., Yankura, J. A., Fogelberg, A. C., & Anderson, B. E. (2010). Treatment of hidradenitis suppurativa with etanercept injection. JAMA Dermatology , 146 (5), 501-504.

Aksakal, A. B., & Adişen, E. (2008). Hidradenitis suppurativa: importance of early treatment; efficient treatment with electrosurgery. Dermatologic Surgery , 34 (2), 228-231.

Alavi, A., & Kirsner, R. S. (2015). Local wound care and topical management of hidradenitis suppurativa. Journal of The American Academy of Dermatology , 73 (5, Supplement 1), S55-S61.

Alavi, A., Anooshirvani, N., Kim, W. B., Coutts, P., & Sibbald, R. G. (2015). Quality-of-life impairment in patients with hidradenitis suppurativa: a canadian study. American Journal of Clinical Dermatology , 16 (1), 61-65.

Alikhan, A. (2016). Hidradenitis Suppurativa. JAMA Dermatology , 152 (6), 736.

Alikhan, A., Lynch, P. J., & Eisen, D. B. (2009). Hidradenitis suppurativa: a comprehensive review. Journal of the American Academy of Dermatology , 60 (4), 539-561.

Alikhan, A., Sayed, C., Alavi, A., Alhusayen, R., Brassard, A., Burkhart, C., et al. (2019). North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations: Part I: Diagnosis, evaluation, and the use of complementary and procedural management. Journal of the American Academy of Dermatology , 81 (1), 76-90.

Alikhan, A., Sayed, C., Alavi, A., Alhusayen, R., Brassard, A., Burkhart, C., et al. (2019). North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part II: Topical, intralesional, and systemic medical management. Journal of the American Academy of Dermatology , 81 (1), 91-101.

American Cancer Society. (July, 2 2018). Radiation Therapy Basics. Retrieved March 5, 2019, from American Cancer Society: https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/radiation/basics.html

Armyra, K., Kouris, A., Markantoni, V., Katsambas, A., & Kontochristopoulos, G. (2017). Hidradenitis suppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients. International Journal of Dermatology , 56 (3), 346-350.

Aryal, A., & Upreti , S. (2017). A BRIEF REVIEW ON SYSTEMIC RETINOIDS. International Journal of Pharmaceutical Sciences and Research , 8 (9), 3630-3639.

Bhuiyan, Z. H., & Chowdhury, M. K. (2016). Acitretin in dermatology - A review. Bangladesh Medical Journal , 45 (2), 98-100.

Bianchi, L., Hansel, K., & Stingeni, L. (2012). Recalcitrant severe hidradenitis suppurativa successfully treated with cyclosporine A. Journal of the American Academy of Dermatology , 67 (6), e278-e279.

Blok, J. L., Li, K., Brodmerkel, C., Horvátovich, P., Jonkman, M. F., & Horváth, B. (2016). Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum. British Journal of Dermatology , 174 (4), 839-846.

Blok, J. L., Spoo, J. R., Leeman, F. W., Jonkman, M. F., & Horváth, B. (2015). Skin-Tissue-sparing Excision with Electrosurgical Peeling (STEEP) : a surgical treatment option for severe hidradenitis suppurativa Hurley stage II/III. Journal of The European Academy of Dermatology and Venereology , 29 (2), 379-382.

Bocchini, S. F., Habr-Gama, A., Kiss, D. R., Imperiale, A. R., & Araujo, S. E. (2003). Gluteal and perianal hidradenitis suppurativa: surgical treatment by wide excision. Diseases of The Colon & Rectum , 46 (7), 944-949.

Boer, J. (2006). Oral Retinoids for Hidradenitis Suppurativa. Retrieved November 8, 2018, from http://eknygos.lsmuni.lt/springer/197/128-135.pdf

Boer, J. (2016). Resolution of hidradenitis suppurativa after weight loss by dietary measures, especially on frictional locations. Journal of the European Academy of Dermatology and Venereology , 30 (5), 895-896.

Boer, J., & Jemec, G. B. (2010). Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. 35 (1), 36-40.

Boer, J., & Nazary, M. (2011). Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer? British Journal of Dermatology , 164 (1), 170-175.

Bong, J. L., Shalders, K., & Saihan, E. (2003). Treatment of persistent painful nodules of hidradenitis suppurativa with cryotherapy. Clinical and Experimental Dermatology , 28 (3), 241-244.

Brantsæter, A. L., Olafsdottir, A. S., Forsum, E., Olsen, S. F., & Thorsdottir, I. (2012). Does milk and dairy consumption during pregnancy influence fetal growth and infant birthweight? A systematic literature review. Food & Nutrition Research , 56.

Brocard, A., Knol, A. C., Khammari, A., & Dréno, B. (2007). Hidradenitis suppurativa and zinc: a new therapeutic approach. A pilot study. Dermatology , 214 (4), 325-327.

Bubna, A. K. (2015). Alitretinoin in Dermatology-An update. Indian Journal of Dermatology , 60 (5), 520.

Bubna, A. K. (2016). Metformin - For the dermatologist. Indian Journal of Pharmacology , 48 (1), 4-10.

Buckley, D. A., & Rogers, S. (1995). Cyclosporin-responsive hidradenitis suppurativa. Journal of the Royal Society of Medicine , 88 (5), 289P-290P.

Canadian Skin Patient Alliance. (2017). Scarred for Life: A National Report of the Patient Experience Living with Hidradenitis Suppurativa.

Cannistrà, C., Finocchi, V., Trivisonno, A., & Tambasco, D. (2013). New perspectives in the treatment of hidradenitis suppurativa: Surgery and brewer's yeast-exclusion diet. Surgery , 154 (5), 1126-1130.

Cassano, N., Alessandrini, G., Mastrolonardo, M., & Vena, G. A. (1999). Peeling agents: toxicological and allergological aspects. Journal of the European Academy of Dermatology and Venereology , 13 (1), 14-23.

Cervantes, J., Eber, A. E., Perper, M., Nascimento, V. M., Nouri, K., & Keri , J. E. (2018). The role of zinc in the treatment of acne: A review of the literature. Dermatologic Therapy , 31 (1).

Chahine, A. A., Nahhas, A. F., Braunberger, T. L., Rambhatla, P. V., & Hamzavi, I. H. (2018). Ertapenem rescue therapy in hidradenitis suppurativa. Journal of the American Academy of Dermatology , 4 (5), 482-483.

Chen, E. Y., Gerstle, T., Verma, K., Treiser, M. D., Kimball, A. B., & Orgill, D. P. (2014). Management of hidradenitis suppurativa wounds with an internal vacuum-assisted closure device. Plastic and Reconstructive Surgery , 133 (3), 370e-377e.

Clark, A. K., Quinonez, R. L., Saric, S., & Sivamani, R. K. (2017). Hormonal therapies for hidradenitis suppurativa: Review. Dermatology Online Journal , 23 (10).

Clemmensen, O. J. (1983). Topical treatment of hidradenitis suppurativa with clindamycin. International Journal of Dermatology , 22 (5), 325-328.

Colboc, H., Fite, C., Cannistra, C., Chaby, G., Maillard, H., Bouscarat, F., et al. (2016). Interest of Brewer's Yeast-Exclusion Diet in the Management of Hidradenitis Suppurativa. Journal of Clinical & Experimental Dermatology Research , 7 (5).

Danby, F. W. (2015). Diet in the prevention of hidradenitis suppurativa (acne inversa). Journal of the American Academy of Dermatology , 73 (5, Supplement 1), S52-S54.

Danby, F. W., Hazen, P. G., & Boer, J. (2015). New and traditional surgical approaches to hidradenitis suppurativa. Journal of the American Academy of Dermatology , 73 (5 (Supplement 1)), S62-S65.

Danesh, M. J., & Kimball, A. B. (2015). Pyrithione zinc as a general management strategy for hidradenitis suppurativa.Journal of the American Academy of Dermatology , 73 (5), e175.

Deckers, I. E., & Prens, E. P. (2016). An Update on Medical Treatment Options for Hidradenitis Suppurativa. Drugs , 76(2), 215-229.

Deckers, I. E., van der Zee, H. H., & Prens, E. P. (2014). Epidemiology of Hidradenitis Suppurativa: Prevalence, Pathogenesis, and Factors Associated with the Development of HS. Current Dermatology Reports , 3 (1), 54-60.

DeFazio, M. V., Economides, J. M., King , K. S., Han, K. D., Shanmugam, V. K., Attinger, C. E., et al. (2016). Outcomes After Combined Radical Resection and Targeted Biologic Therapy for the Management of Recalcitrant Hidradenitis Suppurativa. Annals of Plastic Surgery , 77 (2), 217-222.

Definition of "adjuvant". (n.d.). Retrieved December 4, 2018, from Collins: https://www.collinsdictionary.com/dictionary/english/adjuvant

Dini, V., Oranges, T., Rotella, L., & Romanelli, M. (2015). Hidradenitis Suppurativa and Wound Management. The International Journal of Lower Extremity Wounds , 14 (3), 236-244.

Downey, K. A., & Becker, T. (2019, January 6). Technique of incision and drainage for skin abscess. Retrieved April 30, 2019, from UpToDate: https://www.uptodate.com/contents/technique-of-incision-and-drainage-for-skin-abscess?search=wide%20excision%20for%20hidradenitis%20suppurativa&topicRef=110073&source=see_link#H9

Downs, A. (2004). SmoothbeamTM laser treatment may help improve hidradenitis suppurativa but not Hailey-Hailey disease. Journal of Cosmetic and Laser Therapy , 6 (3), 163-164.

Drugs.com. (n.d.). Adalimumab. Retrieved January 18, 2019, from Drugs.com: https://www.drugs.com/mtm/adalimumab.html

DynaMed Plus. (2016, August 9). Retrieved September 11, 2018, from EBSCO Health: http://www.dynamed.com/topics/dmp~AN~T115217/Hidradenitis-suppurativa#Overview-and-Recommendations

Edlich, R. F., Silloway, K. A., Rodeheaver , G. T., & Cooper, P. H. (1986). Epidemiology, pathology, and treatment of axillary hidradenitis suppurativa. The Journal of Emergency Medicine , 4 (5), 369-378.

epocrates. (n.d.). benzoyl peroxide topical. Retrieved December 20, 2018, from epocrates: https://online.epocrates.com/drugs/207/benzoyl-peroxide-topical/Pharmacology

epocrates. (n.d.). clindamycin. Retrieved December 17, 2018, from epocrates: https://online.epocrates.com/drugs/50805/clindamycin/Adverse-Reactions

epocrates. (n.d.). clindamycin topical . Retrieved December 23, 2018, from epocrates: https://online.epocrates.com/drugs/51005/clindamycin-topical/Adverse-Reactions

epocrates. (n.d.). dapsone. Retrieved December 22, 2018, from epocrates: https://online.epocrates.com/drugs/18805/dapsone/Adverse-Reactions

epocrates. (n.d.). dapsone. Retrieved December 22, 2018, from epocrates: https://online.epocrates.com/drugs/18812/dapsone/Safety-Monitoring

epocrates. (n.d.). ertapenem. Retrieved December 22, 2018, from epocrates: https://online.epocrates.com/drugs/268505/ertapenem/Adverse-Reactions

epocrates. (n.d.). ertapenem. Retrieved December 22, 2018, from epocrates: https://online.epocrates.com/drugs/268513/ertapenem/Pregnancy-Lactation

epocrates. (n.d.). ertapenem. Retrieved December 22, 2018, from epocrates: https://online.epocrates.com/drugs/268512/ertapenem/Safety-Monitoring

epocrates. (n.d.). Humira. Retrieved 2018, from epocrates: https://online.epocrates.com/noFrame/?ICID=eolepocratesheaderbutton

epocrates. (n.d.). metronidazole. Retrieved December 11, 2018, from epocrates: https://online.epocrates.com/drugs/25605/metronidazole/Adverse-Reactions

epocrates. (n.d.). metronidazole. Retrieved December 19, 2018, from epocrates: https://online.epocrates.com/drugs/25613/metronidazole/Pregnancy-Lactation

epocrates. (n.d.). metronidazole. Retrieved December 21, 2018, from epocrates: https://online.epocrates.com/drugs/25612/metronidazole/Safety-Monitoring

epocrates. (n.d.). moxifloxacin. Retrieved December 11, 2018, from epocrates: https://online.epocrates.com/drugs/219705/moxifloxacin/Adverse-Reactions

epocrates. (n.d.). moxifloxacin. Retrieved December 21, 2018, from epocrates: https://online.epocrates.com/drugs/219712/moxifloxacin/Safety-Monitoring

epocrates. (n.d.). resinol. Retrieved December 23, 2018, from epocrates: https://online.epocrates.com/drugs/otcs/376005/Resinol/Adverse-Reactions

epocrates. (n.d.). rifampin. Retrieved December 11, 2018, from epocrates: https://online.epocrates.com/drugs/28005/rifampin/Adverse-Reactions

epocrates. (n.d.). rifampin. Retrieved December 11, 2018, from epocrates: https://online.epocrates.com/u/10c281/rifampin/Safety+Monitoring

epocrates. (n.d.). tetracycline. Retrieved December 22, 2018, from epocrates: https://online.epocrates.com/drugs/8012/tetracycline/Safety-Monitoring

Esmann, S., & Jemec, G. B. (2011). Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Dermato-Venereologica , 91 (3), 328-332.

Fabbrocini, G., França, K., Lotti, T., Marasca, C., Annunziata, M. C., Cacciapuoti, S., et al. (2018, January 25). Intralesional Diode Laser 1064 nm for the Treatment of Hidradenitis Suppurativa: A Report of Twenty Patients. Open Access Macedonian Journal of Medical Sciences.

Fadel, M. A., & Tawfik, A. A. (2015). New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: a single-blind, randomized, comparative study. Clinical and Experimental Dermatology , 40 (2), 116-122.

Finley, E. M., & Ratz, J. L. (1996). Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second-intention healing. Journal of the American Academy of Dermatology , 34 (3), 465-469.

Fröhlich, D., Baaske, D., & Glatzel, M. (2000). [Radiotherapy of hidradenitis suppurativa--still valid today?]. Strahlentherapie Und Onkologie , 176 (6), 286-289.

Garg, A., Kirby, J. S., Lavian, J., Lin, G., & Strunk, A. (2017). Sex- and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States. JAMA Dermatology , 153 (8), 760-764.

Gooderham, M., & Papp, K. (2015). The psychosocial impact of hidradenitis suppurativa. Journal of the American Academy of Dermatology , 73 (5, Supplement 1), S19-S22.

Grant, A., Gonzalez, T., Montgomery, M. O., Cardenas, V., & Kerdel, F. A. (2010). Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial. Journal of the American Academy of Dermatology , 62 (2), 205-217.

Guillet, A., Brocard, A., Ngohou, K. B., Graveline, N., Leloup, A. G., Ali, D., et al. (2015). Verneuil's disease, innate immunity and vitamin D: a pliot study. Journal of the European Academy of Dermatology and Venereology , 29 (7), 1347-1353.

Gulliver, W., Zouboulis, C. C., Prens, E., Jemec, G. B., & Tzellos, T. (2016). Evidence-based approach to the treatment of hidradenitis suppurativa/acne inversa, based on the European guidelines for hidradenitis suppurativa. Reviews in Endocrine and Metabolic Disorders , 17 (3), 343-351.

Hamzavi, I. H., Griffith, J. L., Riyaz, F., Hessam, S., & Bechara, F. G. (2015). Laser and light-based treatment options for hidradenitis suppurativa. Journal of the American Academy of Dermatology , 73 (5 Supplement 1), S78-S81.

Hazen, P. G., & Hazen, B. P. (2010). Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization. Dermatologic Surgery , 36 (2), 208-213.

Hessam, S., Sand, M., Meier, N. M., Gambichler, T., Scholl, L., & Bechara, F. G. (2016). Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa. Journal of Dermatological Science , 84 (2), 197-202.

Hidradenitis Suppurativa Foundation Inc. (n.d.). Surgical and Laser Management of HS. Retrieved May 27, 2019, from Hidradenitis Suppurativa Foundation, Inc.: https://www.hs-foundation.org/surgical-laser-management-hs/

Hidradenitis Suppurativa Foundation, Inc. (n.d.). HS Biologics and Immunosuppressant Treatments. Retrieved September 9, 2018, from Hidradenitis Suppurativa Foundation, Inc.: https://www.hs-foundation.org/biologics-immunosuppressant-treatments/

Highton, L., Chan, W. Y., Khwaja, N., & Laitung, J. K. (2011). Treatment of hidradenitis suppurativa with intense pulsed light: a prospective study. Plastic and Reconstructive Surgery , 128 (2), 459-465.

Horváth, B., Janse, I. C., & Sibbald, G. R. (2015). Pain management in patients with hidradenitis suppurativa. Journal of The American Academy of Dermatology , 73 (5, Supplement 1), S47-S51.

Huang, C. M., & Kirchhof, M. G. (2017). A New Perspective on Isotretinoin Treatment of Hidradenitis Suppurativa: A Retrospective Chart Review of Patient Outcomes. Dermatology , 233 (2-3), 120-125.

Humphries, L. S., Kueberuwa, E., Beederman, M., & Gottlieb, L. J. (2016). Wide excision and healing by secondary intent for the surgical treatment of hidradenitis suppurativa: A single-center experience. Journal of Plastic Reconstructive and Aesthetic Surgery , 69 (4), 554-566.

Ingram, J. R., Woo, P. N., Chua, S. L., Ormerod , A. D., Desai, N., Kai, A. C., et al. (2015). Interventions for hidradenitis suppurativa. Cochrane Database of Systematic Reviews (10).

Iwasaki, J., Marra, D. E., Fincher, E. F., & Moy, R. L. (2008). Treatment of hidradenitis suppurativa with a nonablative radiofrequency device. Dermatologic Surgery , 34 (1), 114-117.

Jemec, G. B. (2002). Methotrexate is of limited value in the treatment of hidradenitis suppurativa. Clinical and Experimental Dermatology , 27 (6), 528-529.

Jemec, G. B., & Wendelboe, P. (1998). Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa. Journal of the American Academy of Dermatology , 39 (6), 971-974.

Join-Lambert, O., Coignard-Biehler, H., Coignard-Biehler, H., Jais, J.-P., Jais, J.-P., Jais, J.-P., et al. (2016). Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients. Journal of Antimicrobial Chemotherapy , 71 (2), 513-520.

Join-Lambert, O., Join-Lambert, O., Coignard, H., Jais, J.-P., Guet-Revillet, H., Poirée, S., et al. (2011). Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology , 222 (1), 49-58.

Kazemi, A., Carnaggio, K., Clark, M., Shephard , C., & Okoye, G. A. (2018). Optimal wound care management in hidradenitis suppurativa. Journal of Dermatological Treatment , 29 (2), 165-167.

Khandalavala, B. N., & Do, M. V. (2016). Finasteride in Hidradenitis Suppurativa: A "Male" Therapy for a Predominantly "Female" Disease. The Journal of Clinical and Aesthetic Dermatology , 9 (6), 44-50.

Kimball, A. B., Okun, M. M., Williams, D. A., Gottlieb, A. B., Papp, K. A., Zouboulis, C. C., et al. (2016). Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa. The New England Journal of Medicine , 375 (5), 422-434.

Kohorst, J. J., Baum, C. L., Otley, C. C., Roenigk, R. K., Schenck, L. A., Pemberton, J. H., et al. (2016). Surgical Management of Hidradenitis Suppurativa: Outcomes of 590 Consecutive Patients. Dermatologic Surgery , 42 (9), 1030-1040.

Kohorst, J. J., Kimball, A. B., & Davis, M. D. (2015). Systemic associations of hidradenitis suppurativa. Journal of The American Academy of Dermatology , 73 (5, Supplement 1), S27-S35.

Kraft, J. N., & Searles, G. E. (2007). Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy. Journal of Cutaneous Medicine and Surgery , 11 (4), 125-131.

Kromann, C. B., Deckers, I. E., Esmann, S., Boer, J., Prens, E. P., & Jemec, G. B. (2014). Risk factors, clinical course and long‐term prognosis in hidradenitis suppurativa: a cross‐sectional study. British Journal of Dermatology , 171 (4), 819-824.

Kromman, C. B., Ibler, K. S., Kristiansen, V. B., & Jemec, G. B. (2014). The influence of body weight on the prevalence and severity of hidradenitis suppurativa. Acta Dermato Venereologica , 94 (5), 553-557.

Lachaine, J., Miron, A., Shear, N., & Alhusayen, R. (2016). The Prevalence And Incidence Of Hidradenitis Suppurativa In Canada: Results From A Population-Based Survey. Value In Health , 19 (3), A123.

Lakshmi, C. (2013). Hormone therapy in acne. Indian Journal of Dermatology, Venereology and Leprology , 79 (3), 322-337.

Lapins, J., Marcusson, J. A., & Emtestam, L. (1994). Surgical treatment of chronic hidradenitis suppurativa: CO2 laser stripping-secondary intention technique. British Journal of Dermatology , 131 (4), 551-556.

Lapins, J., Sartorius, K., & Emtestam, L. (2002). Surgical treatment of chronic hidradenitis suppurativa: CO2 laser stripping-secondary intention technique. British Journal of Dermatology , 47 (2), 280-285.

Lashen, H. (2010). Role of metformin in the management of polycystic ovary syndrome. Therapeutic Advances in Endocrinology and Metabolism , 1 (3), 117-128.

Lee, A., & Fischer, G. (2015). A case series of 20 women with hidradenitis suppurativa treated with spironolactone. Australasian Journal of Dermatology , 56 (3), 192-196.

Lee, E. Y., Alhusayen, R., Lansang, P., Shear, N., & Yeung, J. (2017). What is hidradenitis suppurativa? Canadian Family Physician , 63 (2), 114-120.

Lee, R. A., & Eisen, D. B. (2015). Treatment of hidradenitis suppurativa with biologic medications. Journal of the American Academy of Dermatology , 73 (5 Supplement 1), S82-S88.

Lexicomp. (n.d.). Retrieved February 26, 2019, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/management-of-food-allergy-nutritional-issues?search=dairy%20free%20diet&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1

Lexicomp. (n.d.). Retrieved February 26, 2019, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/dietary-carbohydrates?search=low%20glycemic%20diet&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#

Lexicomp. (n.d.). Acitretin: Drug information. Retrieved November 28, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/acitretin-drug-information?search=acitretin&source=panel_search_result&selectedTitle=1~69&usage_type=panel&kp_tab=drug_general&display_rank=1#F130244

Lexicomp. (n.d.). Adalimumab (including biosimilars of adalimumab): Drug information. Retrieved November 26, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/adalimumab-including-biosimilars-of-adalimumab-drug-information?search=adalimumab&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1#F130486

Lexicomp. (n.d.). Alitretinoin (Systemic) (United States: Not available) (systemic): Drug information. Retrieved November 28, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/alitretinoin-systemic-united-states-not-available-systemic-drug-information?search=alitretinoin&source=panel_search_result&selectedTitle=1~10&usage_type=panel&display_rank=1#F20504553

Lexicomp. (n.d.). Clindamycin (systemic): Drug information. Retrieved November 30, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/clindamycin-systemic-drug-information?search=clindamycin&source=panel_search_result&selectedTitle=1~145&usage_type=panel&display_rank=1#F8008053

Lexicomp. (n.d.). Colchicine: Drug information. Retrieved January 24, 2019, from Lexicomp: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/colchicine-drug-information?search=colchicine&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1#F154285

Lexicomp. (n.d.). Cyclosporine (ciclosporin) (systemic): Drug information. Retrieved January 23, 2019, from Lexicomp: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/cyclosporine-ciclosporin-systemic-drug-information?search=cyclosporine&source=panel_search_result&selectedTitle=1~145&usage_type=panel&display_rank=1#F8012561

Lexicomp. (n.d.). Cyproterone (United States: Not available): Drug information. Retrieved November 24, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/cyproterone-united-states-not-available-drug-information?search=cyproterone%20acetate&source=panel_search_result&selectedTitle=1~32&usage_type=panel&kp_tab=drug_general&display_rank=1#F155782

Lexicomp. (n.d.). Dienogest (United States: Not available): Drug information. Retrieved November 24, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/dienogest-united-states-not-available-drug-information?search=dienogest&source=panel_search_result&selectedTitle=1~10&usage_type=panel&kp_tab=drug_general&display_rank=1#F13450889

Lexicomp. (n.d.). Drospirenone and estradiol: Drug information. Retrieved November 24, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/drospirenone-and-estradiol-drug-information?search=drospirenone&source=search_result&selectedTitle=1~27&usage_type=default&display_rank=1#F1884110

Lexicomp. (n.d.). Dutasteride: Drug information. Retrieved January 5, 2019, from Lexicomp: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/dutasteride-drug-information?search=dutasteride&source=panel_search_result&selectedTitle=1~30&usage_type=panel&kp_tab=drug_general&display_rank=1#F163842

Lexicomp. (n.d.). Ertapenem: Drug information. Retrieved December 1, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/ertapenem-drug-information?search=ertapenem&source=panel_search_result&selectedTitle=1~44&usage_type=panel&kp_tab=drug_general&display_rank=1#F166515

Lexicomp. (n.d.). Finasteride: Drug information. Retrieved November 24, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/finasteride-drug-information?search=finasteride&source=panel_search_result&selectedTitle=1~48&usage_type=panel&kp_tab=drug_general&display_rank=1#F171283

Lexicomp. (n.d.). Hidradenitis suppurativa: Treatment. Retrieved November 30, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/hidradenitis-suppurativa-treatment?search=hidradenitis%20suppurativa&source=search_result&selectedTitle=2~61&usage_type=default&display_rank=2#H10646808

Lexicomp. (n.d.). Isotretinoin: Drug information. Retrieved November 28, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/isotretinoin-drug-information?search=isotretinoin&source=panel_search_result&selectedTitle=1~131&usage_type=panel&kp_tab=drug_general&display_rank=1#F185160

Lexicomp. (2018, December 31). Laser and light therapy of lower extremity telangietasias, reticular veins, and small vericose veins. Retrieved from UptoDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/laser-and-light-therapy-of-lower-extremity-telangiectasias-reticular-veins-and-small-varicose-veins?search=laser%20and%20light%20therapy&source=search_result&selectedTitle=1~150&usage_type=default&di

Lexicomp. (n.d.). Major side effects of systemic glucocorticoids. Retrieved January 25, 2019, from Lexicomp: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/major-side-effects-of-systemic-glucocorticoids?search=systemic%20steroids&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H6

Lexicomp. (n.d.). Metformin: Drug information. Retrieved November 24, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/metformin-drug-information?search=metformin&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1#F193840

Lexicomp. (n.d.). Methotrexate: Drug information. Retrieved February 26, 2019, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/methotrexate-drug-information?search=methotrexate&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1#F194534

Lexicomp. (n.d.). Metronidazole (systemic): Drug information. Retrieved November 30, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/metronidazole-systemic-drug-information?search=metronidazole&source=panel_search_result&selectedTitle=1~145&usage_type=panel&display_rank=1#F8771023

Lexicomp. (n.d.). Minocycline: Drug information. Retrieved January 24, 2019, from Lexicomp: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/minocycline-drug-information?search=minocycline&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1#F196882

Lexicomp. (n.d.). Moxifloxacin (systemic): Drug information. Retrieved November 30, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/moxifloxacin-systemic-drug-information?search=moxifloxacin&source=panel_search_result&selectedTitle=1~92&usage_type=panel&display_rank=1#F9347991

Lexicomp. (2018, July 30). Photodynamic therapy. Retrieved February 26, 2019, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/photodynamic-therapy?search=photodynamic%20therapy&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H4096647797

Lexicomp. (n.d.). Rifampin (rifampicin): Drug information. Retrieved November 30, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/rifampin-rifampicin-drug-information?search=rifampicin&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1#F218166

Lexicomp. (n.d.). Spironolactone: Drug information. Retrieved November 24, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/spironolactone-drug-information?search=spironolactone&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1#F222842

Lexicomp. (n.d.). Tetracycline: Drug information. Retrieved November 30, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/tetracycline-drug-information?search=systemic%20tetracycline&source=panel_search_result&selectedTitle=1~148&usage_type=panel&kp_tab=drug_general&display_rank=1#F51192965

Lexicomp. (n.d.). Zinc gluconate: Drug information. Retrieved February 24, 2019, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/zinc-gluconate-drug-information?search=zinc%20gluconate&source=panel_search_result&selectedTitle=1~10&usage_type=panel&kp_tab=drug_general&display_rank=1#F248679

Lin, C. (2011). Electrosurgery. Retrieved March 5, 2019, from DermNet NZ: https://www.dermnetnz.org/topics/electrosurgery/

Madan, V., Hindle, E., Hussain, W., & August, P. J. (2008). Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser. British Journal of Dermatology , 159 (6), 1309-1314.

Mahmoud, B. H., Tierney, E., Hexsel, C. L., Pui, J., Ozog, D. M., & Hamzavi, I. H. (2010). Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser. Journal of The American Academy of Dermatology , 62 (4), 637-645.

Malvasi, A., Tinelli, A., Buia, A., & De Luca, G. F. (2009). Possible long-term teratogenic effect of isotretinoin in pregnancy. European Review for Medical and Pharmacological Sciences , 13 (5), 393-396.

Mandal, A., & Watson, J. (2005). Experience with different treatment modules in hidradenitis suppuritiva: A study of 106 cases. The Surgeon-Journal of The Royal Colleges of Surgeons of Edinburgh and Ireland , 3 (1), 23-26.

Martin, K. A., & Barbieri, R. L. (2018, September 21). Overview of the use of combined estrogen-progestin oral contraceptives. Retrieved November 24, 2018, from UpToDate: https://www-uptodate-com.ledproxy2.uwindsor.ca/contents/overview-of-the-use-of-combined-estrogen-progestin-oral-contraceptives?search=oral%20contraceptive%20pills&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1#H1790858368

Mehdizadeh, A., Hazen, P. G., Bechara, F. G., Zwingerman, N., Moazenzadeh, M., Bashash, M., et al. (2015). Recurrence of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis. Journal of the American Academy of Dermatology , 73 (5 (Supplement 1), S70-S77.

Melkun, E. T., & Few, J. W. (2005). The use of biosynthetic skin substitute (Biobrane) for axillary reconstruction after surgical excision for hidradenitis suppurativa. Plastic and Reconstructive Surgery , 115 (5), 1385-1388.

Micheletti, R. G. (2014). Natural history, presentation, and diagnosis of hidradenitis suppurativa. Seminars in Cutaneous Medicine and Surgery , 33 (3 Supplement), S51-S53.

Mikkelsen, P. R., Dufour, D. N., Zarchi, K., & Jemec, G. B. (2015). Recurrence rate and patient satisfaction of CO2 laser evaporation of lesions in patients with hidradenitis suppurativa: a retrospective study. Dermatologic Surgery , 41 (2), 255-260.

Miller, I. M., Ellervik, C., Vinding, G. R., Zarchi, K., Ibler, K. S., Knudsen, K. M., et al. (2014). Association of metabolic syndrome and hidradenitis suppurativa. JAMA Dermatology , 150 (12), 1273-1280.

Morgan, W. P., & Leicester, G. (1982). The role of depilation and deodorants in hidradenitis suppurativa. JAMA Dermatology , 118 (2), 101-102.

Mortimer, P. S., Dawber, R. P., Gales, M. A., & Moore, R. A. (1986). A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa. British Journal of Dermatology , 115 (3), 263-268.

Moses, R. G., Luebcke, M., Davis, W. S., Coleman, K. J., Tapsell, L. C., Petocz, P., et al. (2006). Effect of a low-glycemic-index diet during pregnancy on obstetric outcomes. The American Journal of Clinical Nutrition , 84 (4), 807-812.

Murase, J. E., Heller, M. M., & Butler, D. C. (2014). Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. Journal of the American Academy of Dermatology , 70 (3), 401.e1-14.

National Cancer Institute at the National Institutes of Health. (n.d.). NCI Dictionary of Cancer Terms. Retrieved January 22, 2019, from National Cancer Institute at the National Institutes of Health: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/folate-antagonist

National Cancer Institute at the National Institutes of Health. (n.d.). NCI Dictionary of Cancer Terms. Retrieved March 7, 2019, from National Cancer Institute at the National Institutes of Health: https://www.cancer.gov/publications/dictionaries/cancer-terms/def/radiofrequency-ablation

National Center for Complementary and Integrative Health. (2016). Complementary, Alternative, or Integrative Health: What’s In a Name? National Center for Complementary and Integrative Health (NCCIH), National Institutes of Health (NIH), US Dept. of Health and Human Services (US HHS).

Nazary, M., Prens, E. P., & Boer, J. (2016). zathioprine lacks efficacy in hidradenitis suppurativa: a retrospective study of nine patients. British Journal of Dermatology , 174 (3), 639-641.

Ngan, V. (2015, July). Fractional laser treatment. Retrieved March 5, 2019, from DermNetNZ: https://www.dermnetnz.org/topics/fractional-laser-treatment/

Ngan, V. (2003). Photodynamic therapy. Retrieved from DermNet NZ: https://www.dermnetnz.org/topics/photodynamic-therapy/

Nicholson, C. L., Hamzavi, I., & Ozog, D. M. (2016). Rapid healing of chronic ulcerations and improvement in range of motion after fractional carbon dioxide (CO2) treatment after CO2 excision of hidradenitis suppurativa axillary lesions: A case report. JAAD Case Reports , 2 (1), 4-6.

Omi, T., & Numano, K. (2014). The Role of the CO2 Laser and Fractional CO2 Laser in Dermatology. Journal of Cosmetic and Laser Therapy , 23 (1), 49-60.

Orgill, D. P. (2019, January 25). Surgical management of hidradenitis suppurativa. Retrieved April 30, 2019, from UpToDate: https://www.uptodate.com/contents/surgical-management-of-hidradenitis-suppurativa

Passeron, T., Khemis, A., & Ortonne, J. P. (2009). Pulsed dye laser-mediated photodynamic therapy for acne inversa is not successful: A pilot study on four cases. Journal of Dermatological Treatment , 20 (5), 297-298.

Perng, P., Zampella, J. G., & Okoye, G. A. (2017). Management of hidradenitis suppurativa in pregnancy. Journal of The American Academy of Dermatology , 76 (5), 979-989.

Piccolo, D., Di Marcantonio, D., Crisman, G., Cannarozzo, G., Sannino, M., Chiricozzi, A., et al. (2014, September 3). Unconventional Use of Intense Pulsed Light. BioMed Research International.

Pink, A. E., Simpson, M. A., Desai, N., Trembath, R. C., & Barker, J. N. (2013). γ-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis. Journal of Investigative Dermatology , 133 (3), 601-607.

Plovanich, M., Weng, Q. Y., & Mostaghimi, A. (2015). Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne. JAMA Dermatology , 151 (9), 941-944.

Ranaweer, A. (2014). Alexandrite laser treatment. Retrieved March 5, 2019, from DermNet NZ: https://www.dermnetnz.org/topics/alexandrite-laser-treatment/

Ranaweera, A. (2014, July). Neodymium YAG laser treatment. (A. Oakley, Editor) Retrieved February 28, 2019, from DermNet NZ: https://www.dermnetnz.org/topics/ndyag-laser-treatment/

Riis, P. T., Boer, J., Saunte, D. M., Deckers, I. E., Emtestam, L., Sartorius, K., et al. (2016). Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series. Journal of the American Academy of Dermatology , 75 (6), 1151-1155.

Saunte, D. M., & Jemec, G. B. (2017). Hidradenitis Suppurativa: Advances in Diagnosis and Treatment. JAMA , 318 (20), 2019-2032.

Scheinfeld, N. (2013). Treatment of hidradenitis supprurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine. Dermatology Online Journal , 19(11), 20616.

Sehgal, V. N., Verma, P., Sawant, S., & Paul, M. (2011). Contemporary surgical treatment of hidradenitis suppurativa (HS) with a focus on the use of the diode hair laser in a case. Journal of Cosmetic & Laser Therapy , 180-190.

Shah, N. (2005). Hidradenitis suppurativa: a treatment challenge. American Family Physician , 72 (8), 1547-1552.

Shlyankevich, J., Chen, A. J., Kim, G. E., & Kimball, A. B. (2014). Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis. Journal of the American Academy of Dermatology, 71 (6), 1144-1150.

Simonart, T. (2010). Hidradenitis suppurativa and smoking. Journal of the American Academy of Dermatology , 62 (1), 149-150.

Smith, M. K., Nicholson, C. L., Parks-Miller, A., & Hamzavi, I. H. (2017). Hidradenitis suppurativa: an update on connecting the tracts. F1000Research , 6.

Soria, A., Canoui-Poitrine, F., Wolkenstein, P., Poli, F., Gabison, G., Pouget, F., et al. (2009). Absence of Efficacy of Oral Isotretinoin in Hidradenitis Suppurativa: A Retrospective Study Based on Patients’ Outcome Assessment. Dermatology , 218 (2), 134-135.

Sotiriou, E., Apalla, Z., Maliamani, F., & Ioannides, D. (2009). Treatment of recalcitrant hidradenitis suppurativa with photodynamic therapy: report of five cases. Clinical and Experimental Dermatology , 34 (7), e235-e236.

Strauss, R. M., Pollock, B., Stables, G. I., Goulden, V., & Cunliffe, W. J. (2005). Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. British Journal of Dermatology , 152 (4), 803-804.

Suárez-Valladares, M. J., Eiris Salvado, N., & Rodríguez Prieto, M. A. (2017). Treatment of hidradenitis suppurativa with intralesional photodynamic therapy with 5-aminolevulinic acid and 630nm laser beam. Journal of Dermatological Science , 85 (3), 241-246.

Thomas, C. L., Gordon, K. D., & Mortimer, P. S. (2014). Rapid resolution of hidradenitis suppurativa after bariatric surgical intervention. Clinical and Experimental Dermatology , 39 (3), 315-317.

Tierney, E., Mahmoud, B. H., Hexsel, C., Ozog, D., & Hamzavi, I. (2009). Randomized control trial for the treatment of hidradenitis suppurativa with a neodymium-doped yttrium aluminium garnet laser. Dermatologic Surgery , 35 (8), 1188-1198.

Trombetta, M., Werts, E. D., & Parda, D. (2010). The role of radiotherapy in the treatment of hidradenitis suppurativa: case report and review of the literature. Dermatology Online Journal , 16 (2), 16.

Tsai, Y., Wang, S., Lu, P., & Tsai, T. (2013). Hidradenitis suppurativa treated with a long-pulsed Alexandrite laser. Dermatologica Sinica , 3.

Tursi, A. (2016). Concomitant hidradenitis suppurativa and pyostomatitis vegetans in silent ulcerative colitis successfully treated with golimumab. Digestive and Liver Disease , 48 (12), 1511-1512.

Tzanetakou, V., Kanni, T., Giatrakou, K., Katoulis, A., Papadavid, E., Netea, M. G., et al. (2016). Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial. JAMA Dermatology , 152 (1), 52-59.

van der Zee, H. H., & Prens, E. P. (2013). Failure of anti-interleukin-1 therapy in severe hidradenitis suppurativa: a case report. Dermatology , 226 (2), 97-100.

van der Zee, H. H., & Prens, E. P. (2011). The anti-inflammatory drug colchicine lacks efficacy in hidradenitis suppurativa. Dermatology , 223 (2), 169-173.

van der Zee, H. H., Boer, J., Prens, E. P., & Jemec, G. B. (2009). The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa. Dermatology , 219 (2), 143-147.

van der Zee, H. H., Prens, E. P., & Boer, J. (2010). Deroofing: A tissue-saving surgical technique for the treatment of mild to moderate hidradenitis suppurativa lesions. Journal of the American Academy of Dermatology , 63 (3), 475-480.

van Hattem, S., Spoo, J. R., Horváth, B., Jonkman, M. F., & Leeman, F. W. (2012). Surgical treatment of sinuses by deroofing in hidradenitis suppurativa. Dermatologic Surgery , 38 (3), 494-497.

van Straalen, K. R., Schneider-Burrus, S., & Prens, E. P. (2018, July 7). Current and future treatment of hidradenitis suppurativa. British Journal of Dermatology .

Vanlaerhoven, A. M., Ardon, C. B., van Straalen, K. R., Vossen, A. R., Prens, E. P., & van der Zee, H. H. (2018). Hurley III Hidradenitis Suppurativa Has an Aggressive Disease Course. Dermatology , 234, 232-233.

Vellaichamy, G., Braunberger, T. L., Nahhas, A. F., & Hamzavi, I. H. (2018). Surgical procedures for hidradenitis suppurativa. Cutis , 102 (1), 13-16.

Verdolini, R., Clayton, N., Smith, A., Alwash, N., & Mannello, B. (2013). Metformin for the treatment of hidradenitis suppurativa: a little help along the way. Journal of the European Academy of Dermatology and Venereology , 27 (9), 1101-1108.

Verdolini, R., Simonacci, F., Menon, S., Pavlou, P., & Mannello, B. (2015). Alitretinoin: a useful agent in the treatment of hidradenitis suppurativa, especially in women of child-bearing age. Italian Journal of Dermatology and Venereology , 150 (2), 155-162.

von der Werth, J. M., & Williams, H. C. (2000). The natural history of hidradenitis suppurativa. Journal of the European Academy of Dermatology and Venereology , 14 (5), 389-392.

Vossen, A. R., van Straalen, K. R., Prens, E. P., & van der Zee, H. H. (2017). Menses and pregnancy affect symptoms in hidradenitis suppurativa: A cross-sectional study. Journal of The American Academy of Dermatology , 76 (1), 155-156.

Wang, S. C., Wang, S. C., Alavi, A., Alhusayen, R., Bashash, M., & Sibbald, R. G. (2015). Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 2: Treatment Options. Advances in Skin and Wound Care , 28 (8), 372-380.

Wang, S. C., Wang, S. C., Sibbald, R. G., Alhusayen, R., Bashash, M., & Alavi, A. (2015). Hidradenitis Suppurativa: A Frequently Missed Diagnosis, Part 1: A Review of Pathogenesis, Associations, and Clinical Features. Advances in Skin & Wound Care , 28 (7), 325-332.

WebMD. (n.d.). Colchicine. Retrieved January 24, 2019, from WebMD: https://www.webmd.com/drugs/2/drug-8640/colchicine-oral/details

WebMD. (2018, October 19). Hidradenitis Suppurativa Medication. Retrieved January 28, 2019, from Medscape: https://emedicine.medscape.com/article/1073117-medication

WebMD. (n.d.). Tetracycline HCL Side Effects by Likelihood and Severity. Retrieved December 11, 2018, from WebMD: https://www.webmd.com/drugs/2/drug-5919/tetracycline-oral/details/list-sideeffects

Wong, D., Walsh, S., & Alhusayen, R. (2016). Low-dose systemic corticosteroid treatment for recalcitrant hidradenitis suppurativa. Journal of the American Academy of Dermatology , 75 (5), 1059-1062.

Xu, L. Y., Wright, D. R., Mahmoud, B. H., Ozog, D. M., Mehregan, D. A., & Hamzavi, I. H. (2011). Histopathologic study of hidradenitis suppurativa following long-pulsed 1064-nm Nd:YAG laser treatment. JAMA Dermatology , 147 (1), 21-28.

Yang, M. F., & Xu, L. Y. (2012). Laser and light-based treatments of hidradenitis suppurativa. Expert Review of Dermatology , 7 (2), 149-158.

Yazdanyar, S., Boer, J., Ingvarsson, G., Szepietowski, J. C., & Jemec, G. B. (2011). Dapsone Therapy for Hidradenitis Suppurativa: A Series of 24 Patients. Dermatology , 222 (4), 342-346.

Zinc gluconate. (2017). Retrieved September 2018, from Drugs.com: https://www.drugs.com/mtm/zinc-gluconate.html

Zouboulis, C. C., Bechara, F. G., Dickinson-Blok, J. L., Gulliver, W., Horváth, B., Hughes, R., et al. (2019). Hidradenitis suppurativa/acne inversa: A practical framework for treatment optimization – systematic review and recommendations from the HS ALLIANCE working group. Journal of the European Academy of Dermatology and Venereology , 33 (1), 19-31.

Zouboulis, C. C., Desai, N., Emtestam, L., Hunger, R. E., Ioannides, D., Juhász, I., et al. (2015). European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. Journal of The European Academy of Dermatology and Venereology , 29 (4), 619-644.

Zouboulis, C., van der Zee, H., Teixeira, H. D., Gammelsaeter, R., Geng, Z., Rhee, S., et al. (2016). Adalimumab treatment is associated with a trend toward reduced need for acute surgical interventions in patients with moderate-to-severe hidradenitis suppurativa. Journal of the American Academy of Dermatology , 74 (5), Supplement 1, Page AB41.